MASTROIANNI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 1.527
AS - Asia 517
EU - Europa 296
SA - Sud America 116
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.470
Nazione #
US - Stati Uniti d'America 1.507
SG - Singapore 275
BR - Brasile 100
CN - Cina 83
HK - Hong Kong 72
IT - Italia 63
DE - Germania 56
VN - Vietnam 35
RU - Federazione Russa 33
IE - Irlanda 30
GB - Regno Unito 27
NL - Olanda 14
FI - Finlandia 12
MX - Messico 12
SE - Svezia 10
IN - India 9
AT - Austria 8
CZ - Repubblica Ceca 8
FR - Francia 8
JP - Giappone 8
PL - Polonia 8
AR - Argentina 7
BD - Bangladesh 7
LT - Lituania 7
ZA - Sudafrica 7
CA - Canada 5
TR - Turchia 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
ES - Italia 3
ID - Indonesia 3
JO - Giordania 3
BE - Belgio 2
CO - Colombia 2
IL - Israele 2
IQ - Iraq 2
IR - Iran 2
PK - Pakistan 2
PY - Paraguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
CR - Costa Rica 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
MA - Marocco 1
MD - Moldavia 1
NP - Nepal 1
RO - Romania 1
TW - Taiwan 1
Totale 2.470
Città #
Wilmington 440
Houston 278
Singapore 167
Woodbridge 81
Hong Kong 71
Ashburn 63
Chandler 59
Fairfield 58
Beijing 52
New York 34
Santa Clara 31
Los Angeles 28
Rome 28
Seattle 22
Cambridge 21
Munich 20
Dublin 18
Ann Arbor 17
The Dalles 17
Ho Chi Minh City 16
Nuremberg 16
São Paulo 12
Buffalo 11
Dearborn 11
Denver 11
Medford 11
Boardman 9
Council Bluffs 9
Hanoi 9
Dallas 8
Helsinki 8
London 8
Tokyo 8
Amsterdam 7
Atlanta 7
Brooklyn 7
Johannesburg 7
Warsaw 7
Brno 6
Mexico City 6
Lawrence 5
Montreal 5
Orem 5
Phoenix 5
Redondo Beach 5
Vienna 5
Chennai 4
Engelhard 4
Manchester 4
Moscow 4
Palo Alto 4
San Francisco 4
Stockholm 4
Amman 3
Colorado Springs 3
Frankfurt am Main 3
Guangzhou 3
Jacksonville 3
Palermo 3
Salvador 3
San Diego 3
Anápolis 2
Belo Horizonte 2
Brussels 2
Campo Bom 2
Chicago 2
Elk Grove Village 2
Fortaleza 2
Guayaquil 2
Hounslow 2
Itapemirim 2
Jakarta 2
Lappeenranta 2
Leeds 2
Messina 2
Miami 2
Milan 2
Mislata 2
Mt. Dora 2
Nanjing 2
North Hollywood 2
North Shields 2
Olomouc 2
Pelotas 2
Pisa 2
Pontedera 2
Querétaro 2
Ribeirão Preto 2
Rio de Janeiro 2
San Jose 2
St. George 2
Sumaré 2
Tashkent 2
Wuxi 2
Xi'an 2
Abaeté 1
Abu Dhabi 1
Addis Ababa 1
Allen Park 1
Alta Floresta 1
Totale 1.854
Nome #
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 354
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 320
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients 282
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 272
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection 230
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 78
Advances in Transcatheter Aortic Valve Therapy in Bicuspid Aortic Valve Disease: Insight into Patient Selection, Management, and Future Directions 76
Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 75
Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy 71
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 70
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 69
Factors influencing place of death and disenrollment among patients receiving specialist palliative care 69
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 62
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 60
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Na{\"i}ve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004?2014 60
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 57
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50~cp/mL 57
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 49
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 48
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 47
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 43
The Wounded Healer: A Phenomenological Study on Hospital Nurses Who Contracted COVID-19 41
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view 33
null 20
Totale 2.543
Categoria #
all - tutte 9.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021112 0 0 0 0 0 31 27 32 7 7 4 4
2021/202269 1 5 3 3 7 3 7 4 12 5 5 14
2022/2023129 5 10 16 10 17 23 12 15 7 7 4 3
2023/2024145 16 5 3 1 9 19 0 4 6 59 1 22
2024/2025637 17 128 63 36 20 71 77 21 60 44 47 53
2025/2026559 93 57 100 127 134 48 0 0 0 0 0 0
Totale 2.543